Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma
Clinical Immunology · 2026-04 · 284 · 110665
DOI: 10.1016/j.clim.2026.110665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2026-04. Verfasst von Afshin Derakhshani und 18 weiteren Autor:innen. Beteiligte Einrichtung: Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Med…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Calgranulin A, Pancreatic Neoplasms, S100 Calcium Binding Protein A6. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministero della Salute, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale".
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal malignancies, underscoring the need for minimally invasive biomarkers to support patient stratification and disease monitoring. In this study, we aimed to identify PDAC-associated immune signatures by reanalyzing a single-cell RNA-sequencing dataset and to validate key findings using flow cytometry in an independent cohort predominantly composed of advanced-stage PDAC. Analysis of peripheral blood mononuclear cells from patients with PDAC and healthy donors revealed increased expression of S100A6, S100A8, and S100A12, particularly within monocytes and dendritic cells. These transcriptional changes were confirmed at the protein level, demonstrating enrichment of S100A6+ monocytes, S100A6+/S100A8+ DCs, activated monocytes, and plasmacytoid DCs in PDAC. Univariate ROC analyses identified S100A6+ plasmacytoid DCs, S100A8+ plasmacytoid DCs, and CD14+CD86+S100A8+ monocytes as candidate PDAC-associated immune features. However, further validation incorporating benign pancreatic conditions and multivariable modeling is required before conclusions can be drawn regarding diagnostic specificity and clinical applicability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, AB, Canada; McCaig Institute for Bone an…
- Experimental Pharmacology Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
- Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
- Radiology Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.
Förderung
- Ministero della Salute
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Zitieren
APA
Derakhshani, A., Di Fonte, R., Porcelli, L., Orang, F. N., Shadbad, M. A., Feriz, A. M., Safarpour, H., Dufour, A., Baradaran, B., Calabrese, A., Testini, M., Memeo, R., Di Meo, G., Vincenti, L., Bhardwaj, S., Racanelli, V., Silvestris, N., Brunetti, O., & Azzariti, A. (2026). Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma. Clinical Immunology, 284, 110665. https://doi.org/10.1016/j.clim.2026.110665
Vancouver
Derakhshani A, Di Fonte R, Porcelli L, Orang FN, Shadbad MA, Feriz AM, et al. Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma. Clinical Immunology. 2026;284:110665. doi:10.1016/j.clim.2026.110665
BibTeX
@article{Derakhshani2026,
author = {Derakhshani, Afshin and Di Fonte, Roberta and Porcelli, Letizia and Orang, Fatemeh Nejadi and Shadbad, Mahdi Abdoli and Feriz, Adib Miraki and Safarpour, Hossein and Dufour, Antoine and Baradaran, Behzad and Calabrese, Angela and Testini, Mario and Memeo, Riccardo and Di Meo, Giovanna and Vincenti, Leonardo and Bhardwaj, Sonali and Racanelli, Vito and Silvestris, Nicola and Brunetti, Oronzo and Azzariti, Amalia},
title = {Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma},
journal = {Clinical Immunology},
year = {2026},
volume = {284},
pages = {110665},
doi = {10.1016/j.clim.2026.110665}
}
EUVIMED